Trials / Sponsors / Clexio Biosciences Ltd.
Clexio Biosciences Ltd.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressi Adjunctive Treatment of Major Depressive Disorder (MDD) | Phase 2 | 2024-03-18 |
| Completed | A Study of CLE-400 (Topical Gel) for the Treatment of Chronic Pruritus in Adult Subjects With Notalgia Paresth Chronic Pruritus in Adult Subjects With Notalgia Paresthetica (NP) | Phase 2 | 2024-01-29 |
| Completed | A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder Adjunctive Treatment of Major Depressive Disorder | Phase 2 | 2019-09-05 |